Antitrust Antitrust

Risk of conflicting remedies is price of doing business, FTC's Slaughter says

By Flavia Fortes
  • 26 Mar 2021 12:43
  • 26 Mar 2021 12:55
Companies should weigh the risk of having conflicting remedies for their transactions in different jurisdictions when planning for their deals, the Federal Trade Commission's acting chair said.

“The risk of conflicting remedies is the price of doing business,” Rebecca Kelly Slaughter said at a virtual conference.*

Slaughter said that while she thinks it’s

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News